Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Expanding the UTHealth Medical Legal Partnership to Improve Mental Health for Low-Income Individuals

4 de noviembre de 2020 actualizado por: Winston Liaw, The University of Texas Health Science Center, Houston
The aim of this study is to test whether participation of low-income patients with health-harming legal needs (HHLNs) in a medical legal partnership (MLP) results in improved mental health, improved quality of life, reduced utilization, and increased resolution of HHLNs.

Descripción general del estudio

Tipo de estudio

Intervencionista

Inscripción (Actual)

160

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Ubicaciones de estudio

    • Texas
      • Houston, Texas, Estados Unidos, 77093
        • Jensen Clinic

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

18 años y mayores (Adulto, Adulto Mayor)

Acepta Voluntarios Saludables

No

Géneros elegibles para el estudio

Todos

Descripción

Inclusion Criteria:

  • low-income individuals (Low-income is defined as earning less than 200% of the Federal Poverty Level)
  • individuals with HHLNs
  • English or Spanish speaking

Exclusion Criteria:

  • self-identified as being at significant and immediate risk due to HHLNs (e.g., a situation that involves imminent risk to the patient such as domestic violence)

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Otro
  • Asignación: Aleatorizado
  • Modelo Intervencionista: Asignación paralela
  • Enmascaramiento: Ninguno (etiqueta abierta)

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Experimental: Medical Legal Partnership
With the medical legal partnership, lawyers are embedded in clinics, and lawyers consult with patients who are identified as having health-harming legal needs (HHLNs). This arm will also receive usual care, which includes consultation with a social worker and a community health worker.
With the medical legal partnership, lawyers are embedded in clinics, and lawyers consult with patients who are identified as having health-harming legal needs (HHLNs). This arm will also receive usual care, which includes consultation with a social worker and a community health worker.
Usual care includes consultation with a social worker and a community health worker.
Comparador activo: Usual Care
Usual care includes consultation with a social worker and a community health worker.
Usual care includes consultation with a social worker and a community health worker.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Stress as assessed by the Perceived Stress Scale
Periodo de tiempo: baseline
The perceived stress scale consists of 10 items, with each item ranging from 0-4, for a total score range of 0-40. A higher score indicates a worse outcome.
baseline
Stress as assessed by the Perceived Stress Scale
Periodo de tiempo: 3 months
The perceived stress scale consists of 10 items, with each item ranging from 0-4, for a total score range of 0-40. A higher score indicates a worse outcome.
3 months
Stress as assessed by the Perceived Stress Scale
Periodo de tiempo: 6 months
The perceived stress scale consists of 10 items, with each item ranging from 0-4, for a total score range of 0-40. A higher score indicates a worse outcome.
6 months
Stress as assessed by the Perceived Stress Scale
Periodo de tiempo: 12 months
The perceived stress scale consists of 10 items, with each item ranging from 0-4, for a total score range of 0-40. A higher score indicates a worse outcome.
12 months

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Anxiety as assessed by the Generalized Anxiety Disorder 7-item scale
Periodo de tiempo: baseline
The Generalized Anxiety Disorder scale consists of 7 items, with each item ranging from 0-3, for a total score range of 0-21. A higher score indicates a worse outcome.
baseline
Anxiety as assessed by the Generalized Anxiety Disorder 7-item scale
Periodo de tiempo: 3 months
The Generalized Anxiety Disorder scale consists of 7 items, with each item ranging from 0-3, for a total score range of 0-21. A higher score indicates a worse outcome.
3 months
Anxiety as assessed by the Generalized Anxiety Disorder 7-item scale
Periodo de tiempo: 6 months
The Generalized Anxiety Disorder scale consists of 7 items, with each item ranging from 0-3, for a total score range of 0-21. A higher score indicates a worse outcome.
6 months
Anxiety as assessed by the Generalized Anxiety Disorder 7-item scale
Periodo de tiempo: 12 months
The Generalized Anxiety Disorder scale consists of 7 items, with each item ranging from 0-3, for a total score range of 0-21. A higher score indicates a worse outcome.
12 months
Depression as assessed by the Center for Epidemiologic Studies Depression Scale
Periodo de tiempo: baseline
The Center for Epidemiologic Studies Depression Scale consists of 20 items, with each item ranging from 0-3, for a total score range of 0-60. A higher score indicates a worse outcome.
baseline
Depression as assessed by the Center for Epidemiologic Studies Depression Scale
Periodo de tiempo: 3 months
The Center for Epidemiologic Studies Depression Scale consists of 20 items, with each item ranging from 0-3, for a total score range of 0-60. A higher score indicates a worse outcome.
3 months
Depression as assessed by the Center for Epidemiologic Studies Depression Scale
Periodo de tiempo: 6 months
The Center for Epidemiologic Studies Depression Scale consists of 20 items, with each item ranging from 0-3, for a total score range of 0-60. A higher score indicates a worse outcome.
6 months
Depression as assessed by the Center for Epidemiologic Studies Depression Scale
Periodo de tiempo: 12 months
The Center for Epidemiologic Studies Depression Scale consists of 20 items, with each item ranging from 0-3, for a total score range of 0-60. A higher score indicates a worse outcome.
12 months
Quality of life as assessed by the Patient-Reported Outcomes Measurement Information System (PROMIS)
Periodo de tiempo: baseline
The Patient-Reported Outcomes Measurement Information System (PROMIS) consists of 29 items, with 28 of the items ranging from 1-5 and 1 item ranging from 0-10, for a total score range of 28-150. A higher score indicates a worse outcome.
baseline
Quality of life as assessed by the Patient-Reported Outcomes Measurement Information System (PROMIS)
Periodo de tiempo: 3 months
The Patient-Reported Outcomes Measurement Information System (PROMIS) consists of 29 items, with 28 of the items ranging from 1-5 and 1 item ranging from 0-10, for a total score range of 28-150. A higher score indicates a worse outcome.
3 months
Quality of life as assessed by the Patient-Reported Outcomes Measurement Information System (PROMIS)
Periodo de tiempo: 6 months
The Patient-Reported Outcomes Measurement Information System (PROMIS) consists of 29 items, with 28 of the items ranging from 1-5 and 1 item ranging from 0-10, for a total score range of 28-150. A higher score indicates a worse outcome.
6 months
Quality of life as assessed by the Patient-Reported Outcomes Measurement Information System (PROMIS)
Periodo de tiempo: 12 months
The Patient-Reported Outcomes Measurement Information System (PROMIS) consists of 29 items, with 28 of the items ranging from 1-5 and 1 item ranging from 0-10, for a total score range of 28-150. A higher score indicates a worse outcome.
12 months
Number of Urgent Care Visits
Periodo de tiempo: baseline
baseline
Number of Urgent Care Visits
Periodo de tiempo: 3 months
3 months
Number of Urgent Care Visits
Periodo de tiempo: 6 months
6 months
Number of Urgent Care Visits
Periodo de tiempo: 12 months
12 months
Number of Emergency Department Visits
Periodo de tiempo: baseline
baseline
Number of Emergency Department Visits
Periodo de tiempo: 3 months
3 months
Number of Emergency Department Visits
Periodo de tiempo: 6 months
6 months
Number of Emergency Department Visits
Periodo de tiempo: 12 months
12 months
Number of Hospital Visits
Periodo de tiempo: baseline
baseline
Number of Hospital Visits
Periodo de tiempo: 3 months
3 months
Number of Hospital Visits
Periodo de tiempo: 6 months
6 months
Number of Hospital Visits
Periodo de tiempo: 12 months
12 months
Percentage of baseline health-harming legal needs that were resolved
Periodo de tiempo: baseline
baseline
Percentage of baseline health-harming legal needs that were resolved
Periodo de tiempo: 3 months
3 months
Percentage of baseline health-harming legal needs that were resolved
Periodo de tiempo: 6 months
6 months
Percentage of baseline health-harming legal needs that were resolved
Periodo de tiempo: 12 months
12 months

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Investigadores

  • Investigador principal: Winston Liaw, MD, MPH, The University of Texas Health Science Center, Houston

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Actual)

14 de febrero de 2019

Finalización primaria (Actual)

11 de septiembre de 2020

Finalización del estudio (Actual)

11 de septiembre de 2020

Fechas de registro del estudio

Enviado por primera vez

11 de enero de 2019

Primero enviado que cumplió con los criterios de control de calidad

11 de enero de 2019

Publicado por primera vez (Actual)

15 de enero de 2019

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

6 de noviembre de 2020

Última actualización enviada que cumplió con los criterios de control de calidad

4 de noviembre de 2020

Última verificación

1 de noviembre de 2020

Más información

Términos relacionados con este estudio

Otros números de identificación del estudio

  • HSC-MS-18-1037

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

No

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Ensayos clínicos sobre Medical Legal Partnership

Suscribir